Jane Street
HZNP

Jane Street’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Jane Street’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-357,700
Closed -$41.4M – 10120
2023
Q3 		$41.4M Sell
357,700
-205,600
-36% -$22.1M 0.01% 640
2023
Q2 		$57.9M Buy
563,300
+375,800
+200% +$39.6M 0.02% 533
2023
Q1 		$20.5M Sell
187,500
-310,600
-62% -$34.3M 0.01% 987
2022
Q4 		$56.7M Buy
498,100
+332,600
+201% +$27.6M 0.03% 466
2022
Q3 		$10.2M Buy
165,500
+83,300
+101% +$5.82M ﹤0.01% 1671
2022
Q2 		$6.56M Sell
82,200
-91,300
-53% -$8.65M ﹤0.01% 2279
2022
Q1 		$18.3M Buy
173,500
+119,500
+221% +$11.6M 0.01% 1338
2021
Q4 		$5.82M Sell
54,000
-113,900
-68% -$12.4M ﹤0.01% 2618
2021
Q3 		$18.4M Buy
167,900
+100,800
+150% +$10.5M 0.01% 1193
2021
Q2 		$6.28M Sell
67,100
-129,700
-66% -$11.9M ﹤0.01% 2304
2021
Q1 		$18.1M Sell
196,800
-30,000
-13% -$2.53M 0.01% 1056
2020
Q4 		$16.6M Buy
226,800
+104,700
+86% +$7.78M 0.01% 1003
2020
Q3 		$9.48M Sell
122,100
-1,900
-2% -$131K 0.01% 1255
2020
Q2 		$6.89M Buy
+124,000
New +$5.31M 0.01% 1496
2020
Q1 		– Sell
-47,700
Closed -$1.73M – 6414
2019
Q4 		$1.73M Buy
+47,700
New +$1.46M ﹤0.01% 2114
2018
Q4 		– Sell
-13,200
Closed -$258K – 6177
2018
Q3 		$258K Sell
13,200
-38,100
-74% -$724K ﹤0.01% 4403
2018
Q2 		$850K Buy
51,300
+39,500
+335% +$602K ﹤0.01% 2953
2018
Q1 		$168K Buy
+11,800
New +$174K ﹤0.01% 4510
2017
Q4 		– Sell
-17,400
Closed -$221K – 5477
2017
Q3 		$221K Sell
17,400
-17,200
-50% -$219K ﹤0.01% 4031
2017
Q2 		$411K Buy
34,600
+13,200
+62% +$164K ﹤0.01% 3269
2017
Q1 		$316K Sell
21,400
-128,400
-86% -$2.08M ﹤0.01% 3374
2016
Q4 		$2.42M Buy
+149,800
New +$2.72M 0.01% 1154
2016
Q3 		– Sell
-21,800
Closed -$359K – 4789
2016
Q2 		$359K Sell
21,800
-11,500
-35% -$186K ﹤0.01% 3113
2016
Q1 		$552K Sell
33,300
-34,500
-51% -$604K ﹤0.01% 2498
2015
Q4 		$1.47M Buy
67,800
+39,400
+139% +$767K 0.01% 1348
2015
Q3 		$563K Buy
+28,400
New +$897K ﹤0.01% 2191

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jane Street's HZNP Position: Q4 2023 in Review

Jane Street sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 13,042 shares — an estimated $1.51M sold.

Jane Street first reported a position in HZNP in Q4 2013 and held it in 30 quarters. The position peaked at $29.2M in Q3 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Jane Street reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Jane Street sold 13,042 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.51M.
  • Jane Street first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 30 quarters.
  • Jane Street's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $29.2M in Q3 2020.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.